Roopal Thakkar

CIK: 0002004979

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)12 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABBV

AbbVie Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

ABBV
AbbVie Inc.
Feb 27, 2026
Tax Payment(F)
Direct
8K shares at avg. $232.08$1.9M
ABBV
AbbVie Inc.
Feb 18, 2026
Award(A)
Direct
6.6K shares-
ABBV
AbbVie Inc.
Feb 18, 2026
Award(A)
Direct
3.3K shares-
ABBV
AbbVie Inc.
Feb 18, 2026
Award(A)
Direct
2.1K shares-
ABBV
AbbVie Inc.
Feb 18, 2026
Award(A)
Direct
6K shares-
ABBV
AbbVie Inc.
Feb 28, 2025
Tax Payment(F)
Direct
4.7K shares at avg. $205.02$959K
ABBV
AbbVie Inc.
Feb 13, 2025
Award(A)
Direct
3.6K shares-
ABBV
AbbVie Inc.
Feb 13, 2025
Award(A)
Direct
3.3K shares-
ABBV
AbbVie Inc.
Feb 13, 2025
Award(A)
Direct
2.1K shares-
ABBV
AbbVie Inc.
Feb 13, 2025
Award(A)
Direct
1.5K shares-
ABBV
AbbVie Inc.
Feb 15, 2024
Award(A)
Direct
1.6K shares-
ABBV
AbbVie Inc.
Feb 15, 2024
Award(A)
Direct
1.5K shares-
ABBV
AbbVie Inc.
Feb 15, 2024
Award(A)
Direct
2.1K shares-
ABBV
AbbVie Inc.
Feb 15, 2024
Award(A)
Direct
5.9K shares-

		Type	Shares	Price		Ownership
Feb 27, 2026	ABBV AbbVie Inc.	Tax Payment(F)	8,037	$232.08	$1,865,227	Direct
Feb 18, 2026	ABBV AbbVie Inc.	Award(A)	6,638	-	$0	Direct
Feb 18, 2026	ABBV AbbVie Inc.	Award(A)	3,346	-	$0	Direct
Feb 18, 2026	ABBV AbbVie Inc.	Award(A)	2,138	-	$0	Direct
Feb 18, 2026	ABBV AbbVie Inc.	Award(A)	6,015	-	$0	Direct
Feb 28, 2025	ABBV AbbVie Inc.	Tax Payment(F)	4,678	$205.02	$959,084	Direct
Feb 13, 2025	ABBV AbbVie Inc.	Award(A)	3,595	-	-	Direct
Feb 13, 2025	ABBV AbbVie Inc.	Award(A)	3,348	-	-	Direct
Feb 13, 2025	ABBV AbbVie Inc.	Award(A)	2,138	-	-	Direct
Feb 13, 2025	ABBV AbbVie Inc.	Award(A)	1,474	-	-	Direct
Feb 15, 2024	ABBV AbbVie Inc.	Award(A)	1,572	-	-	Direct
Feb 15, 2024	ABBV AbbVie Inc.	Award(A)	1,476	-	-	Direct
Feb 15, 2024	ABBV AbbVie Inc.	Award(A)	2,140	-	-	Direct
Feb 15, 2024	ABBV AbbVie Inc.	Award(A)	5,900	-	-	Direct

1-14 of 14 transactions

About Thakkar Roopal

Thakkar Roopal (SEC CIK 0002004979) files insider reports with the SEC as EVP, R&D and CSO of AbbVie Inc. (ABBV).

Signal8 holds 5 ownership filings by Thakkar Roopal, all Form 4s, filed between Feb 7, 2025 and Mar 3, 2026. Those filings report 14 transactions, from Feb 15, 2024 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thakkar Roopal's filings is in NORTH CHICAGO, IL.

Recent filings by Thakkar Roopal

Feb 27, 2026: Tax withholding of ABBV shares (Form 4, code F).
Feb 18, 2026: Grants or awards of ABBV shares (4 lines, Form 4, code A).
Feb 28, 2025: Tax withholding of ABBV shares (Form 4, code F).
Feb 13, 2025: Grants or awards of ABBV shares (4 lines, Form 4, code A).
Feb 15, 2024: Grants or awards of ABBV shares (4 lines, Form 4, code A).

Other insiders filing for AbbVie Inc. (ABBV)

Carethers John, Director
Quaggin Susan E, Director
RAPP EDWARD J, Director
Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER
FALK THOMAS J, Director
WADDELL FREDERICK H, Director

How to read Form 4 transaction codes